Shigeru Yasue
Direktor/Vorstandsmitglied bei HuLA immune, Inc.
Profil
Shigeru Yasue is currently a Director at HuLA immune, Inc. He was previously a Director at TMS Co., Ltd.
Aktive Positionen von Shigeru Yasue
| Unternehmen | Position | Beginn |
|---|---|---|
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Shigeru Yasue
| Unternehmen | Position | Ende |
|---|---|---|
| TMS CO., LTD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TMS CO., LTD. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
